Literature DB >> 11806395

Brucellar spondylitis: MRI findings.

D Ozaksoy1, K Yücesoy, M Yücesoy, I Kovanlikaya, A Yüce, S Naderi.   

Abstract

This study was carried out to identify the distinguishing features of brucellosis on magnetic resonance imaging (MRI). MRI examinations were performed in 14 patients with spinal brucellosis. A 1-T Magnetom (Erlangen, Siemens) was used to obtain T1-weighted (TR/TE 500/30) and T2-weighted (TR/TE 2000/80/20) spin echo sequences, in both sagittal and axial planes. Thirty-three percent of the vertebrae and 18 levels of disc were involved in the 14 brucellar spondylitis cases. Eleven patients (79.8%) with discitis revealed anterior superior vertebral body involvement. Fourteen (77.7%) of the levels with discitis displayed soft tissue swelling without presence of abscess formation. Seven facet joints of five patients with discitis displayed signal increase after contrast enhancement. Vertebral body signal changes without morphologic changes marked signal increase in the intervertebral disc on T2-weighted and contrast-enhanced sequences, and soft tissue involvement without abscess formation can be accepted as specific MRI features of brucellar spondylitis. The facet joint signal changes following contrast enhancement is another MRI sign of spinal brucellosis, which has not been mentioned so far.

Entities:  

Mesh:

Year:  2001        PMID: 11806395      PMCID: PMC3611537          DOI: 10.1007/s005860100285

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  14 in total

1.  A case of spondylodiscitis with spinal epidural abscess due to Brucella.

Authors:  Dae-Hyun Kim; Young-Dae Cho
Journal:  J Korean Neurosurg Soc       Date:  2008-01-20

2.  Value of magnetic resonance imaging in brucellar spondylodiscitis.

Authors:  Xiaohui Yang; Qin Zhang; Xinghua Guo
Journal:  Radiol Med       Date:  2014-05-27       Impact factor: 3.469

Review 3.  Atypical imaging features of tuberculous spondylitis: case report with literature review.

Authors:  Rita Momjian; Mina George
Journal:  J Radiol Case Rep       Date:  2014-11-30

4.  Brucellar spondylodiscitis: magnetic resonance imaging features with conventional sequences and diffusion-weighted imaging.

Authors:  O Oztekin; C Calli; Z Adibelli; O Kitis; C Eren; T Altinok
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

5.  A diagnostic model for differentiating tuberculous spondylitis from pyogenic spondylitis on computed tomography images.

Authors:  Xiaoyang Liu; Meimei Zheng; Jianmin Sun; Xingang Cui
Journal:  Eur Radiol       Date:  2021-03-25       Impact factor: 5.315

6.  Brucellar spondylodiscitis: comparison of patients with and without abscesses.

Authors:  Figen Kaptan; Hakki Mustafa Gulduren; Aysegul Sarsilmaz; Hasan Kamil Sucu; Serap Ural; Ilknur Vardar; Nejat Ali Coskun
Journal:  Rheumatol Int       Date:  2012-07-29       Impact factor: 2.631

7.  Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].

Authors:  Emine Alp; Rahmi Kemal Koc; Ahmet Candan Durak; Orhan Yildiz; Bilgehan Aygen; Bulent Sumerkan; Mehmet Doganay
Journal:  BMC Infect Dis       Date:  2006-04-11       Impact factor: 3.090

8.  The Diagnostic Value of MRI in Brucella Spondylitis With Comparison to Clinical and Laboratory Findings.

Authors:  Ali Baradaran Bagheri; Koorosh Ahmadi; Niaz Mohamad Jafari Chokan; Bita Abbasi; Reza Akhavan; Ehsan Bolvardi; Somayeh Soroureddin
Journal:  Acta Inform Med       Date:  2016-03-26

9.  Spondylodiscitis revisited.

Authors:  Andreas F Mavrogenis; Panayiotis D Megaloikonomos; Vasileios G Igoumenou; Georgios N Panagopoulos; Efthymia Giannitsioti; Antonios Papadopoulos; Panayiotis J Papagelopoulos
Journal:  EFORT Open Rev       Date:  2017-11-15

10.  Diagnosing pyogenic, brucella and tuberculous spondylitis using histopathology and MRI: A retrospective study.

Authors:  Tao Li; Tao Liu; Zhensong Jiang; Xingang Cui; Jianmin Sun
Journal:  Exp Ther Med       Date:  2016-08-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.